Skip to main content

Table 2 Change in SAS score

From: Impact of ambulatory palliative care on symptoms and service outcomes in cancer patients: a retrospective cohort study

 

Baseline SAS Score

Follow-up SAS score

p-value

Baseline NRS ≥ 4

n (%)

Median (IQR)

n (%)

Median (IQR)

 

n (%)

n (%) with NRS ≥ 1-point improvement

n (%) with NRS ≥ 4 at first follow-up

Sleep disturbance

177 (71.1)

3 (1,6)

76 (30.5)

2 (0,5)

< 0.001

84 (49.1)

21 (24.1)

18 (39.1)

Anorexia

187 (75.1)

3 (1,7)

74 (29.7)

2 (0,5)

0.720

93 (49.8)

22 (21.5)

16 (32.7)

Nausea

180 (72.3)

1 (0,5)

75 (30.1)

1 (0,3)

0.137

51 (28.3)

14 (27.5)

7 (30.4)

Bowel

183 (73.5)

3 (1,7)

75 (30.1)

3 (1,5)

0.062

89 (48.6)

34 (21.9)

25 (53.1)

Dyspnoea

176 (70.7)

2 (0,5)

75 (30.1)

2 (0,4)

0.580

63 (35.8)

14 (22.2)

11 (44.0)

Fatigue

188 (75.5)

7 (5,8)

75 (30.1)

3 (1,5)

0.059

155 (82.6)

34 (21.9)

53 (66.3)

Paina

186 (74.7)

6 (3,8)

76 (30.5)

2 (0,4)

0.002

128 (68.8)

28 (21.9)

42 (52.5)

Mood

176 (70.1)

4 (1,6)

71 (28.5)

6 (4,7)

0.002

96 (54.5)

26 (27.1)

26 (48.1)

Other

25 (10.1)

7 (6,9)

12 (4.8)

5 (1,7)

0.021

22 (88)

4 (18.2)

2 (18.2)

Wellbeing/QOL

177 (71.1)

5 (4,7)

72 (28.9)

2 (0,5)

< 0.001

134 (75.7)

356 (26.1)

49 (63.6)

Symptom composite score, mean (SD)

183 (73.5)

30.9 (15.5)

75 (30.1)

25.9 (13.4)

0.028

   
  1. QOL Quality of life, SD Standard deviation
  2. aFor pain cut-off of NRS ≥ 2 improvement used; p-values derived from Wilcoxon signed rank test